 |
| About Us |
Sanofi-aventis U.S., based in Bridgewater, NJ, and employing 15,000 people across the country, is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives. Our extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines. Read more
|
|
|
|
|
| Quick Links |
|
|
|
| Latest News |
|
| March 12, 2010 |
| Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX® U.S. Prescribing Information |
|
|
|
|
| March 11, 2010 |
| Sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc. |
|
|
|
|
| March 10, 2010 |
| New Campaign Provides Nasal Allergy Sufferers "Clean Sweep" Tips for Spring Allergy Season |
|
|
|
|
| March 03, 2010 |
| Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer |
|
|
|
|
